Skip to main content
. 2021 Sep 7;8:681614. doi: 10.3389/fsurg.2021.681614

Table 4.

Treatment-services discussed and attitudes related to oncofertility services.

Medical oncologists (28) Surgical oncologists (33) p-value All oncologists (61) BCPs (125) p-value
Positive attitudes toward oncofertility
Yes 24 (85.7)* 26 (78.8) 0.41 50 (82.0)
No 1 (3.6) 1 (3.0) 2 (3.3)
Did not know 3 (10.7) 6 (18.2) 9 (14.7)
Oncofertility discussed with provider/reproductive age patient
Yes 23 (82.1) 24 (72.7) 0.384 47 (77.1) 33 (26.4) <0.001
No 5 (17.9) 9 (27.3) 14 (22.9) 92 (73.6)
Specific oncofertility options discussed
Egg Banking 23 (82.1) 28 (84.8) 1 51 (83.6) 67 (53.6) <0.001
Embryo Banking 20 (71.4) 27 (81.8) 0.336 47 (77.0) 36 (28.8) <0.001
OTCa 18 (64.3) 25 (75.8) 0.328 43 (70.5) 16 (12.8) <0.001
GnRH-a therapy 18 (64.3) 17 (51.5) 0.315 35 (57.4) 7 (5.6) <0.001
All options 12 (42.9) 13 (39.4) 0.784 25 (41.0) 4 (3.2) <0.001
Oncofertility discussed by provider to adolescent patients
Yes 25 (89.3) 25 (75.8) 0.171 50 (82.0)
No 3 (10.7) 8 (24.2) 11 (18.0)
Oncofertility discussed by provider to pre-adolescent patients
Yes 17 (60.7) 18 (54.5) 0.627 35 (57.4)
No 11 (39.3) 15 (45.5) 26 (42.6)
Psychological counseling/support offered
Yes 28 (100) 32 (97.0) 1.000b 60 (98.4) 107 (85.6) 0.007
No 0 (0) 1 (3.3) 1 (1.6) 18 (14.4)
Partner was offered to be part of the discussion of oncofertility
Yes 25 (89.3) 32 (97.0) 0.325b 57 (93.4) 24 (19.2)
No 3 (10.7) 1 (3.0) 4 (6.6) 91 (72.8) <0.001
No partner 10 (8)
a

Ovarian Tissue Cryopreservation;

b

Fisher's exact test.

*

n (%).